Characterization of Intestinal Microbiomes of Hirschsprung's Disease Patients with or without Enterocolitis Using Illumina-MiSeq High-Throughput Sequencing.
Hirschsprung-associated enterocolitis (HAEC) is a life-threatening complication of Hirschsprung's disease (HD). Although the pathological mechanisms are still unclear, studies have shown that HAEC has a close relationship with the disturbance of intestinal microbiota. This study aimed to investigate the characteristics of the intestinal microbiome of HD patients with or without enterocolitis. During routine or emergency surgery, we collected 35 intestinal content samples from five patients with HAEC and eight HD patients, including three HD patients with a history of enterocolitis who were in a HAEC remission (HAEC-R) phase. Using Illumina-MiSeq high-throughput sequencing, we sequenced the V4 region of bacterial 16S rRNA, and operational taxonomic units (OTUs) were defined by 97% sequence similarity. Principal coordinate analysis (PCoA) of weighted UniFrac distances was performed to evaluate the diversity of each intestinal microbiome sample. The microbiota differed significantly between the HD patients (characterized by the prevalence of Bacteroidetes) and HAEC patients (characterized by the prevalence of Proteobacteria), while the microbiota of the HAEC-R patients was more similar to that of the HAEC patients. We also observed that the specimens from different intestinal sites of each HD patient differed significantly, while the specimens from different intestinal sites of each HAEC and HAEC-R patient were more similar. In conclusion, the microbiome pattern of the HAEC-R patients was more similar to that of the HAEC patients than to that of the HD patients. The HD patients had a relatively distinct, more stable community than the HAEC and HAEC-R patients, suggesting that enterocolitis may either be caused by or result in a disruption of the patient's uniquely adapted intestinal flora. The intestinal microbiota associated with enterocolitis may persist following symptom resolution and can be implicated in the symptom recurrence.
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yuqing
Y
Li
Department of Medical Oncology &Therapeutics Research, City of Hope, Duarte, California, United States of America.
Valeriy
V
Poroyko
Department of Surgery, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zhilong
Z
Yan
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Liya
L
Pan
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yi
Y
Feng
Institute of Molecular Ecology and Evolution, SKLEC & IECR, East China Normal University, Shanghai, China.
Peihua
P
Zhao
Department of Surgery, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zhoulonglong
Z
Xie
Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Li
L
Hong
D041963:Bacteroidetes / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity; D002675:Child, Preschool; D004760:Enterocolitis / Q000150:complications / Q000235:genetics* / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D005260:Female; D000069196:Gastrointestinal Microbiome / Q000235:genetics*; D059014:High-Throughput Nucleotide Sequencing; D006627:Hirschsprung Disease / Q000150:complications / Q000235:genetics* / Q000382:microbiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012336:RNA, Ribosomal, 16S / Q000235:genetics
D012336:RNA, Ribosomal, 16S